Suplemento 1 - Colegio de Medicina Interna de México AC | CMIM

Consensowith unfractionated heparin in the treatment of venous thromboembolism.Arch Intern Med 2000;160:181-8.66. Warkentin TE. Heparin-induced trombocitopenia: Pathogenesisand management. Br J Haematol 2003;121:535-55.67. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy forvenous thromboembolic disease. The Seventh ACCP Conferenceon Antithrombotic and Thrombolytic Therapy Chest2004;126:401S-28S.68. Buller HR, Davidson BL, Decousus H, et al. Fondaparinux orenoxaparin for the initial treatment of symptomatic deep venousthrombosis. Ann Intern Med 2004;140:867-73.69. Hainer J, Per Sprogel P, Lindenstroem E. An example basedon the low-molecular weight heparin, tinzaparin. Sem ThrombHaemost 2004;30(Suppl):3-9.70. Anderson JC. Advances in anticoagulation therapy: The roleof selective inhibitors of factor Xa and thrombin in thromboprophylaxisafter major orthopedic surgery. Sem Thromb Haemost2004;6:609-18.71. Martínez-Murillo C. Hacía un consenso nacional de tromboembolismovenoso. Gac Med Mex 2000;136:133-7.72. Kaboli P, Henderson MC, White RH. DVT prophylaxis and anticoagulationin the surgical patient. Clin Med N Am 2003;87:77-110.73. Sanderink GJ, Liboux AL. The pharmacokinetics and pharmacodynamicsof enoxaparin in obese volunteers. Clin PharmacolTher 2002;72:308-18.74. Carrillo Esper R, Carrillo Córdova JR. Profi laxis de la enfermedadtromboembólica venosa en cirugía y anestesiología.México: Alfi l, 2005.75. Huber O, Bournameaux H, Bourst F, Rohner A. Postoperativepulmonary embolism after hospital discharge. Arch Surg1992;127:310-3.76. Nicolaides AN, Breddin HK, Fareed J, et al. CardiovascularDisease Educational and Research Trust and the InternationalUnion of Angiology. Prevention of venous thromboembolism.International Consensus Statement. Int Angiol 1997;16:3-38.77. Holger J, Schünemann H, Munger H, et al. Methodology forguideline development for the Seventh American Collage ofChest Physicians conference on antithrombotic and thrombolytictherapy. Chest 2004;126:174S-8S.78. Wilson WA, Ghavari AE, Koike T, et al. International consensusstatement on preliminary classifi cation criteria for defi nitiveantiphospolipid syndrome: Report of an international workshop.Arthritis Rheum 1999;42:1309-11.79. Petri M. Epidemiology of the antiphospolipid syndrome. JAutoinmun 2000;15:145-51.80. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of twointensities of warfarin for the prevention of recurrent thrombosisin patients with the antiphospholipid antibody syndrome. NEngl J Med 2003;349:1133-8.81. Danilenko-Dixon DR, Heit JA, Watkins T, et al. Risk factorsfor deep vein thrombosis and pulmonary embolism duringpregnancy or the postpartum period: a population-based casecontrolstudy. Am J Obstet Gynecol 2001;184:104-10.82. Dilley A, Austin H, El-Jamil mM, Hooper W, et al. Geneticfactors associated with thrombosis in pregnancy in a UnitedStates population. Am J Obstet Gynecol 2000;183:1271-7.83. Carter C. Oral contraceptives and thrombosis. Curr Opin PulmMed 2000;6:296-300.84. Miller J, Benjamin KS, Heidi DN. Postmenopausal estrogenreplacement and risk for venous thromboembolism: A systematicreview and meta-analysis for de U.S. preventive servicesTask Force. Ann Intern Med 2002;136:680-90.85. Asell JE. Air travel venous thromboembolism – is the evidencein? N Engl J Med 2001;345:828-9.86. Cesarone MR, Belcaro G, Nicolardes AN. Venous thrombosisfrom air travel: The LONFLIT3 study. Prevention with aspirin vs.low-molecular-weight heparin (LMWH)- in high-risk subjects:A randomized trial. Angiology 2002;53:1-6.87. Lee AYY. Management of thrombosis in cancer: Primaryprevention and secondary prophylaxis. Br J Haematol2004;128:291-302.88. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA: Prognosisof cancers associated with venous thromboembolism. N EnglJ Med 2000;343:1846-50.89. Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weightheparin versus a coumarin for the prevention of recurrentvenous thromboembolism in patients with cancer. New EnglJ Med 2003;349:146-53.90. Evidence Based Guidelines Group American Burn Association.Deep venous thrombosis prophylaxis in burns. J Burn CareRehabil 2001;22(suppl):67S-69S.91. Hankey GJ. Low-molecular weight heparins or heparinoidsversus standard non fractioned heparin for acute ischaemicstroke. Cochrane Corner. Stroke 2005;36:2045-6.92. Ferro JM, Canhao P, Stam J, Bousser JS, BarinagarrementeriaF, for the ISCVT Investigators. Prognosis of cerebral vein anddural sinus thrombosis: results of the International Study onCerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke2004;35:664-70.93. Stawicki SP, Grossman MD, Cipolla J, et al. Deep venousthrombosis and pulmonary embolism in trauma patients: anoverstatement of the problem. Am Surg 2005;71:387-92.94. Hirsh J, Hull RD. Venous Thromboembolism: Natural history,diagnosis, and management. Florida: CRC Press, 1988.95. Bergqvist D. Postoperative thromboembolism: Frequency,aethiology, prophylaxis. New York: Springer Verlag, 1983.96. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratifi cation ofsurgical and nonsurgical patients for venous thromboembolicdisease. Semin Hematol 2001;38(suppl5):12-19.97. Gensini GF, Prisco D, Falciani M, Comeglio M, Colella A.Identifi cation of candidates for prevention of venous thromboembolism.Semin Thromb Hemost 1997;23;55-67.98. Drucker EA, Rivitz SM, Shepard JA, et al. Acute pulmonaryembolism: assessment of helical CT for diagnosis. Radiology1998;209:235-41.99. Egeberg O. Inherited antithrombin III deficiency causingthrombophilia. Thromb Diath Haemorrh 1965;13:516-20.100. Mannucci PM, Vigano S. Deficiencies of protein C, an inhibitorof blood coagulation. Lancet 1982;2:463-7.101. Hessner MJ, Luhm RA, Pearson SL, et al. Prevalence ofprothrombin G20210A, factor V G16991A (Leiden) and methylenetetrahydrofolatereductase (MTHFR) C677T in sevendifferent populations determined by multiplex allele specifi cPCR. Thromb Haemost 1999;81:733-8.102. Keenan CR, White RH. Age as a risk factor for venousthromboembolism after major surgery. Curr Op Pulmon Med2005;11:398-402.103. Christen Y, Wutschert R, Weimer D, et al. Effects of intermittentpneumatic compression on venous haemodynamics andfi brinolytic activity. Blood Coagul Fibrinolysis 1997;8:185-90.S36 Medicina Interna de México Volumen 22, Suplemento 1, 2006